Literature DB >> 12960076

Expression of type 2 iodothyronine deiodinase in corticotropin-secreting mouse pituitary tumor cells is stimulated by glucocorticoid and corticotropin-releasing hormone.

Osamu Araki1, Tadashi Morimura, Takayuki Ogiwara, Haruo Mizuma, Masatomo Mori, Masami Murakami.   

Abstract

We identified the presence of iodothyronine deiodinase in AtT-20 mouse pituitary tumor cells that secrete corticotropin. Iodothyronine deiodinating activity in AtT-20 cells fulfills all the characteristics of type 2 iodothyronine deiodinase (D2), including the inhibition by thyroid hormones, the insensitivity to inhibition by 6-propyl-2-thiouracil, and the low Michaelis-Menten constant value for T4. Northern analysis using mouse D2 cRNA probe demonstrated the hybridization signal of approximately 7.0 kb in size in AtT-20 cells. D2 activity and D2 mRNA were stimulated by glucocorticoid in a dose-dependent manner but were not stimulated by testosterone or beta-estradiol. D2 expression was stimulated by (Bu)2cAMP, and CRH in a dose-dependent manner in the presence of dexamethasone. These results suggest the previously unrecognized role of local thyroid hormone activation by D2 in the regulation of pituitary corticotrophs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12960076     DOI: 10.1210/en.2003-0419

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  5 in total

1.  Type 2 iodothyronine deiodinase is highly expressed in medullary thyroid carcinoma.

Authors:  Erika L Souza Meyer; Iuri M Goemann; José Miguel Dora; Marcia S Wagner; Ana Luiza Maia
Journal:  Mol Cell Endocrinol       Date:  2008-04-22       Impact factor: 4.102

2.  Thyroid hormone activation in vascular smooth muscle cells is negatively regulated by glucocorticoid.

Authors:  Nagaoki Toyoda; Saori Yasuzawa-Amano; Emiko Nomura; Azusa Yamauchi; Kumiko Nishimura; Chizuko Ukita; Satoshi Morimoto; Atsushi Kosaki; Toshiji Iwasaka; John W Harney; P Reed Larsen; Mitsushige Nishikawa
Journal:  Thyroid       Date:  2009-07       Impact factor: 6.568

3.  A novel pathway regulates thyroid hormone availability in rat and human hypothalamic neurosecretory neurons.

Authors:  Imre Kalló; Petra Mohácsik; Barbara Vida; Anikó Zeöld; Zsuzsanna Bardóczi; Ann Marie Zavacki; Erzsébet Farkas; Andrea Kádár; Erik Hrabovszky; Rafael Arrojo E Drigo; Liping Dong; László Barna; Miklós Palkovits; Beáta A Borsay; László Herczeg; Ronald M Lechan; Antonio C Bianco; Zsolt Liposits; Csaba Fekete; Balázs Gereben
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

4.  Concurrent TSHR mutations and DIO2 T92A polymorphism result in abnormal thyroid hormone metabolism.

Authors:  Eunkuk Park; Jaehoon Jung; Osamu Araki; Katsuhiko Tsunekawa; So Young Park; Jeonghyun Kim; Masami Murakami; Seon-Yong Jeong; Sihoon Lee
Journal:  Sci Rep       Date:  2018-07-04       Impact factor: 4.379

5.  Essential Role of GATA2 in the Negative Regulation of Type 2 Deiodinase Gene by Liganded Thyroid Hormone Receptor β2 in Thyrotroph.

Authors:  Hideyuki Matsunaga; Shigekazu Sasaki; Shingo Suzuki; Akio Matsushita; Hirotoshi Nakamura; Hiroko Misawa Nakamura; Naoko Hirahara; Go Kuroda; Hiroyuki Iwaki; Kenji Ohba; Hiroshi Morita; Yutaka Oki; Takafumi Suda
Journal:  PLoS One       Date:  2015-11-16       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.